Reddoch James F.

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
3.4
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Reddoch James F.'s trades of Royalty Pharma PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-06-10 2022-06-08 S Sale
52,029 -47.2%
49.99
US$3,741,854
52,029 -47.2% 49.99 US$3,741,854
2022-05-31 2022-05-27 S Sale
83,342 +34.5%
451.68
US$4,255,602
83,342 +34.5% 451.68 US$4,255,602
2022-05-23 2022-05-19 S Sale
76,700 +26.6%
322.67
US$3,431,282
76,700 +26.6% 322.67 US$3,431,282
2021-06-08 2021-06-08 S Sale
50,000 -3.8%
46.43
US$2,321,540
50,000 -3.8% 46.43 US$2,321,540
2021-06-08 2021-06-07 PlS Planned sale
2,210 -0.2%
47.01
US$103,896
2,210 -0.2% 47.01 US$103,896
2021-06-08 2021-06-07 PlS Planned sale
47,790 -3.5%
46.57
US$2,225,523
47,790 -3.5% 46.57 US$2,225,523
2021-06-08 2021-06-04 S Sale
100,000 -6.8%
44.60
US$4,459,730
100,000 -6.8% 44.60 US$4,459,730
2021-04-16 2021-04-14 S Sale
55,714 -21.8%
42.10
US$2,345,593
55,714 -21.8% 42.10 US$2,345,593
2021-04-14 2021-04-12 S Sale
359 -0.1%
42.32
US$15,193
359 -0.1% 42.32 US$15,193
2021-03-24 2021-03-22 S Sale
43,927 -14.6%
46.32
US$2,034,519
43,927 -14.6% 46.32 US$2,034,519
2021-03-04 2021-03-02 S Sale
3,510 -1.2%
47.84
US$167,925
3,510 -1.2% 47.84 US$167,925
2021-03-04 2021-03-02 S Sale
96,490 -24.1%
46.89
US$4,524,233
96,490 -24.1% 46.89 US$4,524,233